MKI67 and non-small cell lung carcinoma: Previous studies in NSCLC have shown that patients whose tumors presented a high Ki67 labeling index (> 30%) showed a poor prognosis, whereas patients with a low Ki67 index (≤ 30%) on tumor specimens, had a better clinical outcome [43, 44].